1700001F09Rik Activators
1700001F09Rik Activators are chemical compounds that facilitate the biological processes in which 1700001F09Rik is inherently involved, through a spectrum of signaling cascades and molecular interactions. Compounds like Forskolin, IBMX, and Dibutyryl cAMP operate through the elevation of cAMP levels, leading to the activation of PKA. This activation sequence can culminate in the phosphorylation of proteins that directly or indirectly influence 1700001F09Rik activity, which is posited to enhance its functional role in cellular processes. Similarly, PMA, functioning as a PKC activator, and Epigallocatechin gallate, known for its kinase inhibitory effects, could alleviate repressive controls or stimulate pathways that bolster the role of 1700001F09Rik. These activators, through their targeted bioactivity, create conditions that are conducive to the potentiation of 1700001F09Rik, without necessitating an increase in its expression or direct activation.
Furthermore, the modulation of intracellular calcium levels by compounds such as A23187 and Thapsigargin, or the action of Ionomycin as a calcium ionophore, triggers calcium-dependent protein kinases that can impact 1700001F09Rik activity. The sphingolipid mediator Sphingosine-1-phosphate enhances cellular dynamics that could tie into the signaling repertoire of 1700001F09Rik, potentially amplifying its functional contribution. In the arena of kinase regulation, LY294002's inhibition of PI3K and U0126's suppression of MEK1/2 can lead to a tilt in the signaling equilibrium, favoring the engagement of 1700001F09Rik in its native biochemical networks. Collectively, these 1700001F09Rik Activators embody a diverse arsenal of molecules that, through their distinct and precise mechanisms, converge on enhancing the activity of 1700001F09Rik, a testament to the intricate web of intracellular signaling that governs protein functionality.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA acts as a diacylglycerol (DAG) analog and a potent activator of protein kinase C (PKC). PKC can phosphorylate a wide range of target proteins, possibly including or affecting regulators of 1700001F09Rik, thus indirectly enhancing the activity of 1700001F09Rik. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which increases intracellular cAMP levels by preventing its breakdown. The increase in cAMP can lead to activation of PKA, which could then enhance the activity of 1700001F09Rik through phosphorylation of associated proteins or pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. Elevated calcium levels can activate calcium-dependent protein kinases, which may subsequently interact with or affect the signaling pathways involving 1700001F09Rik, thereby potentially enhancing its activity. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can lead to phosphorylation of proteins that interact with or affect the activity of 1700001F09Rik, potentially enhancing its function. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea with kinase inhibitory activity. By inhibiting certain kinases, it may relieve negative regulation on pathways that involve 1700001F09Rik, leading to its enhanced activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium concentration. This can activate calcium/calmodulin-dependent protein kinases, potentially affecting pathways or proteins that regulate the activity of 1700001F09Rik, thus indirectly enhancing its functional activity. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
db-cAMP is another cAMP analog that activates PKA. This activation can lead to the phosphorylation of proteins within the signaling pathways that 1700001F09Rik is involved in, therefore enhancing its activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P interacts with its G-protein-coupled receptors to activate intracellular signaling pathways, including those that lead to actin cytoskeletal rearrangements. These rearrangements could enhance the activity of 1700001F09Rik by affecting its interaction with other cellular components. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of PI3K. Inhibition of PI3K can lead to altered signaling downstream, potentially affecting pathways that involve 1700001F09Rik, leading to its enhanced activity through indirect effects. | ||||||